Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thomas Weisel Venture Partners (TWVP) was a San Francisco-based venture capital firm that functioned as the venture arm of the investment bank Thomas Weisel Partners. The firm specialized in early-stage and growth-stage investments, with a significant focus on the healthcare and information technology sectors. Within healthcare, TWVP targeted high-growth opportunities in biotechnology, medical devices, and healthcare services, managing dedicated funds such as Thomas Weisel Healthcare Venture Partners. The firm provided strategic capital to innovative companies aiming to disrupt traditional medical markets or introduce novel therapeutic technologies. Following the acquisition of its parent company by Stifel Financial in 2010, the venture group transitioned to managing its legacy portfolio rather than initiating new investment cycles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thomas Weisel Venture Partners.